ADC THERAPEUTICS SA -REDH ($ADCT) posted quarterly earnings results for Q4 2025 on Tuesday, March 10th. The company reported earnings of -$0.04 per share, beating estimates of -$0.27 by $0.23. The company also reported revenue of $23,060,000, beating estimates of $21,817,800 by $1,242,200.
You can see Quiver Quantitative's $ADCT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADC THERAPEUTICS SA -REDH Hedge Fund Activity
We have seen 68 institutional investors add shares of ADC THERAPEUTICS SA -REDH stock to their portfolio, and 42 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TCG CROSSOVER MANAGEMENT, LLC added 10,000,000 shares (+719.3%) to their portfolio in Q4 2025, for an estimated $35,300,000
- EVENTIDE ASSET MANAGEMENT, LLC added 3,364,067 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,875,156
- NANTAHALA CAPITAL MANAGEMENT, LLC added 3,209,144 shares (+141.6%) to their portfolio in Q4 2025, for an estimated $11,328,278
- POINT72 ASSET MANAGEMENT, L.P. removed 3,121,034 shares (-38.4%) from their portfolio in Q4 2025, for an estimated $11,017,250
- LYNX1 CAPITAL MANAGEMENT LP removed 1,325,848 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,680,243
- PROSIGHT MANAGEMENT, LP added 1,005,035 shares (+13.5%) to their portfolio in Q4 2025, for an estimated $3,547,773
- BLACKROCK, INC. added 915,610 shares (+20.3%) to their portfolio in Q4 2025, for an estimated $3,232,103
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
